查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2019785

流式细胞技术市场规模、份额、成长及全球产业分析：按类型、应用和地区划分，并预测至2026-2034年

Flow Cytometry Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 148 Pages | 商品交期: 请询问到货日

价格

流式细胞技术市场成长要素

受对先进诊断和研究工具需求不断增长的推动，全球流式细胞技术市场正经历强劲增长。预计到2025年，该市场规模将达到66.6亿美元，2026年将成长至72.2亿美元，到2034年将达到141.2亿美元。这一显着增长反映了流式细胞技术在疾病诊断、药物研发和临床研究领域日益广泛的应用。

流式细胞技术是一种强大的分析技术，它利用雷射检测来测量细胞和颗粒的物理和化学性质。它在细胞计数、生物标记检测和疾病诊断中发挥着至关重要的作用，尤其是在肿瘤学、免疫学和感染疾病领域。

市场趋势

推动市场发展的关键趋势之一是新一代流式细胞技术系统的研发。这些先进的仪器能够进行多参数分析，使研究人员可以同时研究多种细胞特性。最新的系统可以同时分析20到30个参数，进而提高疾病检测的准确性并提升研究成果。

自动化也是一项关键趋势，各公司纷纷采用机器人样本製备系统和整合解决方案来提高效率和可重复性。此外，先进软体和人工智慧的融合正在简化数据分析并改善临床决策。

市场成长要素

流式细胞技术市场的成长主要受癌症、爱滋病和白血病等慢性疾病日益普遍的驱动。随着疾病负担的加重，人们对能够提供准确快速结果的先进诊断技术的需求也日益增长。

另一个重要因素是研发投入的增加。製药和生物技术公司越来越多地将流式细胞技术应用于药物发现、免疫肿瘤学和干细胞研究。重组DNA技术和抗体研究的日益普及也进一步推动了市场需求。

此外，人们对早期疾病诊断重要性的认识不断提高，以及先进检测技术的引入，正在推动流式细胞技术在临床和研究环境中的广泛应用。

抑制因子

儘管流式细胞仪具有诸多优势，但市场仍面临一些挑战。流式细胞技术设备高成本，从7.5万美元到10万美元不等，这限制了其普及应用，尤其是在小规模检查室和发展中地区。

此外，技术复杂性和对专业技术人员的需求限制了其广泛应用。设备体积较大和维护要求较高也阻碍了市场成长。这些因素可能会在对成本敏感的市场中减缓其普及速度。

細項分析

按产品/服务

市场区隔分为仪器、耗材和试剂以及软体和服务。受分析仪器和细胞分选仪需求不断增长的推动，仪器细分市场预计将占据主导地位，到2026年将占市场份额的50.48%。这些仪器技术的不断进步也促进了它们的广泛应用。

透过技术

依技术划分，市场可分为基于细胞的系统和以微珠为基础的系统。预计到2026年，基于细胞的系统将占据市场主导地位，市占率达到59.83%，这主要得益于其在疾病诊断中的广泛应用。同时，以微珠为基础的技术因其高灵敏度和成本效益，预计将快速成长。

透过使用

目前，研究领域占最大份额，预计到2026年将达到70.32%，主要得益于生命科学和生物技术研究领域投资的增加。临床领域也因诊断应用需求的成长而发展壮大。

最终用户

医院和诊断检查室是这一细分市场的主要驱动力，预计到 2026 年将占市场份额的 36.52%，这主要得益于患者数量的增加和对准确诊断工具日益增长的需求。

区域趋势

北美地区拥有许多主要企业和先进的医疗基础设施，预计2025年将引领全球流式细胞技术市场，占39.42%的市场份额。该地区透过高额的研发投入和对先进技术的早期应用，持续保持其主导地位。

欧洲占据较大份额，这主要得益于活性化的研究活动和监管机构的核准。亚太地区预计将实现最快成长，这主要得益于健康意识的提高、研究能力的增强以及先进诊断工具的日益普及。

拉丁美洲、中东和非洲的市场正在逐步成长，这得益于医疗基础设施的改善和慢性病盛行率的上升。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2025年主要国家爱滋病毒和癌症盛行率
  • 流式细胞技术的技术进步
  • 产业重大发展动态－併购、联盟与收购
  • 新冠疫情的影响：全球流式细胞技术市场

第五章：2021-2034年全球流式细胞技术市场分析、洞察与预测

  • 市场分析、洞察与预测：按产品和服务划分。
    • 装置
      • 分析器
      • 分类机
    • 试剂和耗材
    • 软体服务
  • 市场分析、洞察与预测：按技术划分
    • 基于细胞
    • 以微珠为基础
  • 市场分析、洞察与预测：按应用领域划分
    • 临床阶段
    • 研究
  • 市场分析、洞察与预测：按最终用户划分
    • 製药和生物技术产业
    • 学术和研究机构
    • 医院/诊断
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区

第六章：北美流式细胞技术市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲流式细胞技术市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太地区流式细胞技术市场分析、洞察与预测（2021-2034年）

  • 国家
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：2021-2034年世界其他地区流式细胞技术市场分析、洞察及预测

第十章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Miltenyi Biotec
    • BD（Becton, Dickinson and Company）
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Sysmex Corporation
    • Apogee Flow Systems Ltd.
    • Sony Biotechnology Inc.
    • DiaSorin SpA
    • BIOMERIEUX
Product Code: FBI107325

Growth Factors of flow cytometry Market

The global flow cytometry market is experiencing strong growth due to increasing demand for advanced diagnostic and research tools. The market was valued at USD 6.66 billion in 2025 and is projected to grow to USD 7.22 billion in 2026, reaching USD 14.12 billion by 2034. This significant expansion reflects the growing application of flow cytometry in disease diagnosis, drug discovery, and clinical research.

Flow cytometry is a powerful analytical technology used to measure physical and chemical characteristics of cells or particles using laser-based detection. It plays a crucial role in cell counting, biomarker detection, and disease diagnosis, particularly in oncology, immunology, and infectious diseases.

Market Trends

One of the major trends shaping the market is the development of next-generation flow cytometry systems. These advanced instruments allow multi-parameter analysis, enabling researchers to study multiple cellular characteristics simultaneously. Modern systems can analyze 20-30 parameters at once, improving accuracy in disease detection and research outcomes.

Automation is another key trend, with companies introducing robotic sample preparation systems and integrated solutions that enhance efficiency and reproducibility. Additionally, the integration of advanced software and artificial intelligence is streamlining data analysis and improving clinical decision-making.

Market Growth Drivers

The growth of the flow cytometry market is primarily driven by the increasing prevalence of chronic diseases such as cancer, HIV/AIDS, and leukemia. The rising disease burden has led to higher demand for advanced diagnostic technologies that provide accurate and rapid results.

Another important driver is the growing investment in research and development. Pharmaceutical and biotechnology companies are increasingly using flow cytometry in drug discovery, immuno-oncology, and stem cell research. The expanding use of recombinant DNA technology and antibody-based research is further boosting market demand.

Moreover, the increased awareness regarding early disease diagnosis and the adoption of advanced laboratory technologies are supporting the widespread use of flow cytometry across clinical and research settings.

Restraining Factors

Despite its advantages, the market faces certain challenges. The high cost of flow cytometry instruments, ranging between USD 75,000 and USD 100,000, limits adoption, especially in small laboratories and developing regions.

Additionally, the technical complexity and requirement for skilled professionals restrict its widespread usage. The bulky nature of instruments and maintenance requirements also act as barriers to market growth. These factors may slow down adoption in cost-sensitive markets.

Segmentation Analysis

By Product & Service

The market is segmented into instruments, consumables & reagents, and software & services. The instruments segment dominates with a 50.48% share in 2026, driven by increasing demand for analyzers and cell sorters. Continuous technological advancements in these instruments support their widespread adoption.

By Technology

Based on technology, the market is divided into cell-based and bead-based systems. The cell-based segment leads with a 59.83% share in 2026, owing to its extensive use in disease diagnosis. Meanwhile, bead-based technology is expected to grow rapidly due to its high sensitivity and cost-effectiveness.

By Application

The research segment holds the largest share, accounting for 70.32% in 2026, driven by increasing investments in life sciences and biotechnology research. The clinical segment is also growing due to rising demand for diagnostic applications.

By End-user

Hospitals and diagnostic laboratories dominate the segment with a 36.52% share in 2026, supported by increasing patient visits and growing need for accurate diagnostic tools.

Regional Insights

North America dominates the global flow cytometry market, accounting for 39.42% share in 2025, with a strong presence of key players and advanced healthcare infrastructure. The region continues to lead due to high R&D investments and early adoption of advanced technologies.

Europe holds a significant share, driven by increasing research activities and regulatory approvals. Asia Pacific is expected to witness the fastest growth due to rising healthcare awareness, expanding research capabilities, and increasing adoption of advanced diagnostic tools.

Latin America and the Middle East & Africa are gradually growing markets, supported by improving healthcare infrastructure and rising prevalence of chronic diseases.

Conclusion

The flow cytometry market is set for robust growth, expanding from USD 6.66 billion in 2025 to USD 14.12 billion by 2034. The growth is driven by increasing prevalence of chronic diseases, technological advancements, and rising research activities. While high costs and technical complexities pose challenges, ongoing innovations and expanding applications in clinical and research fields are expected to drive long-term market expansion. Overall, the market presents significant opportunities for stakeholders in the healthcare and life sciences sectors.

Segmentation By Product & Service

  • Instruments
    • Analyzer
    • Sorter
  • Reagents & Consumables
  • Software & Services

By Technology

  • Cell Based
  • Bead Based

By Application

  • Clinical
  • Research

By End-user

  • Pharmaceutical & Biotechnology Industries
  • Academic & Research Organizations
  • Hospital & Diagnostics
  • Others

By Geography

  • North America (By Product & Service, By Technology, By Application, By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product & Service, By Technology, By Application, By Country/sub-region)
    • Germany (By Application)
    • U.K. (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product & Service, By Technology, By Application, By Country/sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Rest of the World

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of HIV and Cancer, By Key Countries, 2025
  • 4.2. Technological Advancements in Flow Cytometry
  • 4.3. Key Industry Developments -Mergers, Partnerships, & Acquisitions
  • 4.4. Impact of COVID-19 on Global Flow Cytometry Market

5. Global Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product & Service
    • 5.1.1. Instruments
      • 5.1.1.1. Analyzer
      • 5.1.1.2. Sorter
    • 5.1.2. Reagents & Consumables
    • 5.1.3. Software & Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Cell Based
    • 5.2.2. Bead Based
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Clinical
    • 5.3.2. Research
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Pharmaceuticals & Biotechnology Industries
    • 5.4.2. Academic & Research Organizations
    • 5.4.3. Hospitals & Diagnostics
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World

6. North America Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product & Service
    • 6.1.1. Instruments
      • 6.1.1.1. Analyzer
      • 6.1.1.2. Sorter
    • 6.1.2. Reagents & Consumables
    • 6.1.3. Software & Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Cell Based
    • 6.2.2. Bead Based
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Clinical
    • 6.3.2. Research
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Pharmaceuticals & Biotechnology Industries
    • 6.4.2. Academic & Research Organizations
    • 6.4.3. Hospitals & Diagnostics
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Application
    • 6.5.2. Canada
      • 6.5.2.1. By Application

7. Europe Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product & Service
    • 7.1.1. Instruments
      • 7.1.1.1. Analyzer
      • 7.1.1.2. Sorter
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Software & Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Cell Based
    • 7.2.2. Bead Based
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Clinical
    • 7.3.2. Research
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Pharmaceuticals & Biotechnology Industries
    • 7.4.2. Academic & Research Organizations
    • 7.4.3. Hospitals & Diagnostics
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Application
    • 7.5.2. Germany
      • 7.5.2.1. By Application
    • 7.5.3. France
      • 7.5.3.1. By Application
    • 7.5.4. Italy
      • 7.5.4.1. By Application
    • 7.5.5. Spain
      • 7.5.5.1. By Application
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Application
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Application

8. Asia Pacific Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product & Service
    • 8.1.1. Instruments
      • 8.1.1.1. Analyzer
      • 8.1.1.2. Sorter
    • 8.1.2. Reagents & Consumables
    • 8.1.3. Software & Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Cell Based
    • 8.2.2. Bead Based
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Clinical
    • 8.3.2. Research
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Pharmaceuticals & Biotechnology Industries
    • 8.4.2. Academic & Research Organizations
    • 8.4.3. Hospitals & Diagnostics
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Application
    • 8.5.2. China
      • 8.5.2.1. By Application
    • 8.5.3. India
      • 8.5.3.1. By Application
    • 8.5.4. Australia
      • 8.5.4.1. By Application
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Application
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Application

9. Rest of the World Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product & Service
    • 9.1.1. Instruments
      • 9.1.1.1. Analyzer
      • 9.1.1.2. Sorter
    • 9.1.2. Reagents & Consumables
    • 9.1.3. Software & Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Cell Based
    • 9.2.2. Bead Based
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Clinical
    • 9.3.2. Research
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Pharmaceuticals & Biotechnology Industries
    • 9.4.2. Academic & Research Organizations
    • 9.4.3. Hospitals & Diagnostics
    • 9.4.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Miltenyi Biotec
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & Services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. BD (Becton, Dickinson and Company)
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & Services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Bio-Rad Laboratories, Inc.
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & Services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Thermo Fisher Scientific Inc.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & Services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. Agilent Technologies, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & Services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Sysmex Corporation
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & Services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Apogee Flow Systems Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & Services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Sony Biotechnology Inc.
      • 10.2.8.1. Overview
      • 10.2.8.2. Products & Services
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. DiaSorin S.p.A.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products & Services
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)
    • 10.2.10. BIOMERIEUX
      • 10.2.10.1. Overview
      • 10.2.10.2. Products & Services
      • 10.2.10.3. SWOT Analysis
      • 10.2.10.4. Recent Developments
      • 10.2.10.5. Strategies
      • 10.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 2: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 3: Global Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 7: North America Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 8: North America Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 9: North America Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Flow Cytometry Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 12: Canada Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 14: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 15: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: Europe Flow Cytometry Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Germany Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: U.K. Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: France Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Italy Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Spain Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Scandinavia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Rest of Europe Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 25: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 26: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: China Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: India Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Japan Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Australia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 33: Southeast Asia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Rest of Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 35: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 36: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 37: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Flow Cytometry Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Flow Cytometry Market Value Share (%), by Product & Service, 2025 & 2034
  • Figure 3: Global Flow Cytometry Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Flow Cytometry Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Flow Cytometry Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Flow Cytometry Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 8: North America Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 9: North America Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 11: North America Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 13: North America Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 15: North America Flow Cytometry Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Flow Cytometry Market Value Share (%), By Country, 2025
  • Figure 17: Europe Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 18: Europe Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 19: Europe Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 23: Europe Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Flow Cytometry Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Flow Cytometry Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 28: Asia Pacific Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 29: Asia Pacific Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Flow Cytometry Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Flow Cytometry Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Rest of the World Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 38: Rest of the World Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 39: Rest of the World Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Rest of the World Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 41: Rest of the World Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Rest of the World Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 43: Rest of the World Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Rest of the World Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 45: Global Flow Cytometry Market Share (%), By Company, 2025